Trials / Completed
CompletedNCT04229433
The Multiple Dose of PK/PD Study of SHR2285 Tablets in Healthy Subjects
A Phase I, Randomized, Single -Blind, Placebo-Controlled, Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SHR2285 Tablets in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 36 (actual)
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The study is a randomized, single-blind, placebo-controlled, multiple-dose escalation Phase I trials. 2 dose groups were designed, 12 subjects in each dose group.The drug was administered single dose and multiple doses.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SHR2285 tablet | Pharmaceutical form: SHR2285 tablet Route of administration: single dose and multiple doses. |
| DRUG | Placebo | Pharmaceutical form: Placebo tablet Route of administration: single dose and multiple doses. |
Timeline
- Start date
- 2020-08-11
- Primary completion
- 2020-11-08
- Completion
- 2020-11-08
- First posted
- 2020-01-18
- Last updated
- 2021-05-25
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04229433. Inclusion in this directory is not an endorsement.